From April 17 to 22, researchers and physicians from NYU Langone Health join colleagues from around the world at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, California.
Below are notable sessions featuring our faculty and trainees. For the full list of NYU Langone presenters, visit the AACR website.
Saturday, April 18
Educational Session
Moving the macroenvironment: How physical activity remodels tumors
Session: Improving Cancer Outcomes by Shaping the Tumor Macroenvironment
Presenter and Session Chair: Dafna Bar-Sagi, PhD
Time: 8:01–8:21AM
Location: Ballroom 6B | Upper Level
Educational Session
Dimensions of structural chromosomal instability in human cancer
Session: New Insights from TCGA Whole-Genome Sequencing
Presenter: Marcin Imielinski, MD, PhD
Time: 1:05–1:25PM
Location: Room 33 | Upper Level
Educational Session
Cardiovascular disease and cancer: A dangerous liaison
Session: Beyond Cardiotoxicity: How Cardiovascular Disease and Systemic Risk Factors Drive Tumorigenesis
Presenter: Kathryn J. Moore, PhD
Time: 1:21–1:41PM
Location: Room 5 | Upper Level
Educational Session
Novel molecular targets in multiple myeloma
Session: Hematological Malignancies: Undruggable Targets and New Frontiers
Presenter and Session Chair: Faith E. Davies, MD
Time: 1:30–1:55PM
Location: Room 30 | Upper Level
Educational Session
Microbiome-driven myeloid remodeling as a mechanism of cachexia and immunotherapy resistance in lung cancer
Session: Clinical and Molecular Phenotyping of Cancer
Presenter and Session Chair: Marcus D. Goncalves, MD, PhD
Time: 1:31PM–1:51PM
Location: Room 15 | Mezzanine Level
Educational Session
Defining the intended use population and ensuring real-world generalizability
Session: Contextual Challenges in Interpreting Performance of Blood-Based Early Cancer Detection Tests
Presenter: Aasma Shaukat, MD, MPH
Time: 2:55–3:10PM
Location: Room 1 | Upper Level
Sunday, April 19
Oral Presentation
Tumor-immune interactions at the verge of necrotic cores
Session: The Necrotic Tumor Microenvironment as an Instigator of Metastatic Aggression and Immuno-evasion
Presenter: Carlos Carmona-Fontaine, PhD
Time: 1:30–1:50PM
Location: Room 14 | Mezzanine Level
Monday, April 20
Oral Presentation
New insights into SHP2 signaling to RAS
Session: Signaling Pathways in Cancer: Dedicated to the Memory of J. Michael Bishop
Presenter and Session Chair: Benjamin G. Neel, MD, PhD
Time: 12:31–12:47PM
Location: Room 30 | Upper Level
Oral Presentation
NG06 – Autocrine LIF signaling: A novel therapeutic target to eliminate inflammatory and immunosuppressive cancer stem cells in LKB1 mutant lung adenocarcinoma
Session: Signaling Pathways in Cancer: Dedicated to the Memory of J. Michael Bishop
Presenter: Ray Pillai, MD
Time: 1:34–1:50PM
Location: Room 30 | Upper Level
Poster
Analysis of tumor and biomarker responses in the VIRAGE Trial, a randomized Phase IIb, open-label, study of nab-paclitaxel and gemcitabine with/without intravenous VCN-01 in patients with metastatic pancreatic cancer (mPDAC)
Session: Phase II and Phase III Clinical Trials
Presenter: Manuel Hidalgo, MD
Time: 2:00–5:00PM
Location: Section 52
Tuesday, April 21
Oral Presentation
Advances in basic science melanoma research
Session: Advances in Melanoma Research and Treatment
Presenter: Eva M. Hernando-Monge, PhD
Time: 12:35–12:55PM
Location: Room 33 | Upper Level
Oral Presentation
Early detection and interception of pancreatic cancer
Session: Turning the Tide in the Fight Against Pancreatic Cancer
Presenter and Session Chair: Anirban Maitra, MD
Time: 1:27–1:42PM
Location: Ballroom 6A | Upper Level
Poster
Plasma proteomics of cancer risk in patients with chronic kidney disease
Session: Genomics, Proteomics, Biomarkers, and Risk Stratification
Presenter: Lucas Mavromatis
Time: 2:00–5:00PM
Location: Section 36
Oral Abstract
Targeting metabolism in BRCA-deficient tumors
Session: Metabolic Signaling and Therapeutic Vulnerabilities in Cancer
Presenter: Maira Di Tano, PhD
Time: 4:05–4:20PM
Location: Ballroom 6 CF | Upper Level
Wednesday, April 22
Oral Presentation
Chromosome imbalances as drivers of immune evasion and therapeutic resistance
Session: Aneuploidy and Mutations in Normal Tissues and Their Role in Cancer Initiation and Cancer Risk
Presenter and Session Chair: Teresa Davoli, PhD
Time: 10:20–10:40AM
Location: Room 5 | Upper Level
